Gout Relief 3310-S

Manufacturer
Bispit Canada Ltd.
Effective date
2025-09-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:34:56

Label at a glance#

ProductGout Relief 3310-S
Active ingredientCOIX LACRYMA-JOBI SEED, MEDICAGO SATIVA WHOLE, BUCKWHEAT, TEA LEAF, MORUS ALBA LEAF, CHICORY ROOT, FU LING, GLUCOSAMINE HYDROCHLORIDE, LICORICE
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

MEDICAGO SATIVA WHOLE 20.00%
CHICORY ROOT 23.00%
GLUCOSAMINE HYDROCHLORIDE 10.00%
BUCKWHEAT 7.00%
TEA LEAF 5.00%
MORUS ALBA LEAF 13.00%
LICORICE 0.20%
FU LING 2.00%
COIX LACRYMA-JOBI SEED 8.00%

INACTIVE INGREDIENT SECTION

This product has a significanteffect on gout, crystal deposits,and hyperuricemia;
elt has an auxiliary effectof mitigating kidney stonesand bladder stones

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

DOSAGE & ADMINISTRATION SECTION

The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;

INDICATIONS & USAGE SECTION

Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus

OTHER SAFETY INFORMATION

Do not use if seal is broken.

Do not eat freshness packet enclosed.

Keep out of direct sunlight, high temperature, and humidity.

Store in a cool, dry place.

WARNINGS SECTION

For your health, please read the followingcarefully
1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
5. This product certainly has significant effect on gout,crystallization and hyperuricemia;

OTC - PURPOSE SECTION

This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labelinglabeling

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85631-006-01Gout Relief 3310-S60 in 1 BOTTLECAPSULE601
85631-006-01Gout Relief 3310-S1.3 g in 1 CAPSULECAPSULE1.31

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85631-00685631-006-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gout Relief 3310-SMEDICAGO SATIVA WHOLE CHICORY ROOTBispit Canada Ltd.3dbf3436-16b9-b793-e063-6394a90a1e712025-09-01WarningsExact identifier
ndc (package): 85631-006-01
ndc (product): 85631-006
ndc11 (package): 85631000601
spl id: 3dbf3436-16ba-b793-e063-6394a90a1e71
spl set id: 3dbf3436-16b9-b793-e063-6394a90a1e71

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.